Avastin Related Clinical Trials
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) [Completed]
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers [Completed]
Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors [Completed]
Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma [Recruiting]
Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer [Active, not recruiting]
Phase I - Pharmacokinetic Comparability Study in Healthy Male Volunteers [Active, not recruiting]
Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer [Active, not recruiting]
Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme [Not yet recruiting]
Phase II Pilot Study of Visudyne� Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab. [Completed]
Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Terminated]
Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas [Completed]
Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy [Recruiting]
Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme [Completed]
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain [Terminated]
Combination Therapy for Age-Related Macular Degeneration. [Completed]
Bevacizumab, Temsirolimus, Valproic Acid, Cetuximab [Recruiting]
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) [Active, not recruiting]
AMG 102 and Avastin for Recurrent Malignant Glioma [Active, not recruiting]
Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma [Active, not recruiting]
A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer [Active, not recruiting]
Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer [Completed]
Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis [Terminated]
Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma [Active, not recruiting]
Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma [Completed]
Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer [Completed]
Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma [Completed]
Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer. [Completed]
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin [Active, not recruiting]
Intravitreal Avastin in Proliferative Retinopathies [Completed]
Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer [Completed]
Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium [Completed]
Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer [Active, not recruiting]
Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer [Completed]
Avastin for PDR (Proliferative Diabetic Retinopathy) [Completed]
Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis [Completed]
Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis [Not yet recruiting]
Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer [Completed]
Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma [Completed]
Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas [Completed]
Intraocular Bevacizumab Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema [Recruiting]
Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma [Completed]
Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC [Completed]
Treatment With Intravitreal Avastin for Large Uveal Melanomas [Completed]
Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions? [Completed]
Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome [Completed]
Intralesional Bevacizumab Injection on Primary Pterygium [Recruiting]
Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion [Completed]
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca. [Completed]
A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) [Terminated]
NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma [Recruiting]
Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer [Recruiting]
HAI Abraxane With Gemcitabine and Bevacizumab [Completed]
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma [Completed]
Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients [Active, not recruiting]
Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients [Recruiting]
Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery [Active, not recruiting]
Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma [Active, not recruiting]
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin [Completed]
Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG) [Completed]
Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan [Completed]
A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma [Recruiting]
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy [Recruiting]
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated [Completed]
Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer [Recruiting]
Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction [Terminated]
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma [Active, not recruiting]
Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer [Completed]
Prospective Randomized Trial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD) [Recruiting]
Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1 [Recruiting]
Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer [Terminated]
Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme [Active, not recruiting]
Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema [Recruiting]
Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure [Suspended]
Valproic Acid and Bevacizumab in Patients With Advanced Cancer [Completed]
Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer [Terminated]
Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma [Active, not recruiting]
Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC [Terminated]
Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma [Active, not recruiting]
Intraarterial Cerebral Infusion of Avastin for Vestibular Schwannoma (Acoustic Neuroma) [Recruiting]
Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma [Completed]
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC [Completed]
Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab [Active, not recruiting]
Intranasal Bevacizumab for HHT-Related Epistaxis [Recruiting]
Nivolumab vs Nivolumab + Bevacizumab vs Nivolumab + Ipilimumab in Metastatic Renal Cell Carcinoma (mRCC) [Recruiting]
Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer [Completed]
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy [Active, not recruiting]
Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies [Active, not recruiting]
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma [Completed]
A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum [Completed]
Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) [Active, not recruiting]
Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse [Terminated]
Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab [Completed]
Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer [Terminated]
Bevacizumab in Treating Patients With Angiosarcoma [Active, not recruiting]
|